NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers

The addition of chemotherapeutic agents to ionizing radiation has improved survival in many malignancies. Cure rates may be further improved by adding novel targeted agents to current radiotherapy or radiochemotherapy regimens. Despite promising laboratory data, progress in the clinical development...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lawrence, Yaacov Richard, Vikram, Bhadrasain, Dignam, James J., Chakravarti, Arnab, Machtay, Mitchell, Freidlin, Boris, Takebe, Naoko, Curran, Walter J., Bentzen, Soren M., Okunieff, Paul, Coleman, C. Norman, Dicker, Adam P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2013
Soggetti:
Commentary
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3536642/
https://ncbi.nlm.nih.gov/pubmed/23231975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs472
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi